We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$700M
AUM Growth
-$4.98M
Cap. Flow
-$12M
Cap. Flow %
-1.71%
Top 10 Hldgs %
65.48%
Holding
53
New
8
Increased
9
Reduced
3
Closed
5

Top Buys

1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$9.54M
2
C icon
Citigroup
C
+$8.53M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$7.03M
4
JD icon
JD.com
JD
+$6.01M
5
AMZN icon
Amazon
AMZN
+$5.11M

Top Sells

1
BIDU icon
Baidu
BIDU
+$24.6M
2
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$9.72M
3
BAC icon
Bank of America
BAC
+$8.01M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.72M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$4.84M

Sector Composition

1 Communication Services 25.8%
2 Consumer Discretionary 20.6%
3 Healthcare 12.96%
4 Technology 12.44%
5 Financials 11.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$169B
$7.04M 1.01%
86,959
– –
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
$6.45M 0.92%
46,000
– –
MSCC
28
DELISTED
Microsemi Corp
MSCC
$5.83M 0.83%
113,240
+40,000
+55% +$2.01M
NXPI icon
29
NXP Semiconductors
NXPI
$68.3B
$5.27M 0.75%
46,600
– –
AMZN icon
30
Amazon
AMZN
$2.69T
$5M 0.71%
+104,000
New +$5.11M
EDU icon
31
New Oriental
EDU
$7.87B
$4.68M 0.67%
+52,998
New +$4.32M
CRM icon
32
Salesforce
CRM
$141B
$4.2M 0.6%
45,000
– –
SLB icon
33
SLB Ltd
SLB
$70.4B
$3.87M 0.55%
55,500
– –
VTRS icon
34
Viatris
VTRS
$20.2B
$3.14M 0.45%
100,000
– –
ZAYO
35
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$2.69M 0.38%
78,080
– –
VNET
36
VNET Group
VNET
$2.2B
$2.52M 0.36%
443,800
– –
MNK
37
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.13M 0.3%
+57,000
New +$2.26M
VIPS icon
38
Vipshop
VIPS
$7.01B
$1.36M 0.19%
155,000
+110,000
+244% +$1.14M
SYBX
39
DELISTED
Synlogic
SYBX
$1.3M 0.19%
+4,576
New +$936K
ZEN
40
DELISTED
ZENDESK INC
ZEN
$999K 0.14%
+34,328
New +$964K
FLNT
41
Fluent
FLNT
$109M
$955K 0.14%
32,467
– –
TEVA icon
42
Teva Pharmaceuticals
TEVA
$37.5B
$933K 0.13%
53,000
– –
TSRO
43
DELISTED
TESARO, Inc.
TSRO
$891K 0.13%
+6,905
New +$857K
ARAV
44
DELISTED
Aravive, Inc. Common Stock
ARAV
$600K 0.09%
40,816
– –
NXPI icon
45
CALL
NXP Semiconductors
NXPI
$68.3B
$585K 0.08%
150,000
– –
ACAD icon
46
Acadia Pharmaceuticals
ACAD
$4.39B
– –
-205,000
Closed -$5.72M
MOMO
47
Hello Group
MOMO
$918M
– –
-75,000
Closed -$2.77M
NBIX icon
48
Neurocrine Biosciences
NBIX
$17.2B
– –
-105,202
Closed -$4.84M
TAL icon
49
TAL Education Group
TAL
$5.67B
– –
-203,604
Closed -$4.15M
ONC
50
BeOne Medicines Ltd
ONC
$32.9B
– –
-10,082
Closed -$454K
1
2

Similar funds

SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
TL
Tirschwell & Loewy New York $731M AUM 15.44% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return
SCA
Secor Capital Advisors New York $485M AUM 3.33% 1-Year Est. Return
SHCM
Stokes & Hubbell Capital Management New Orleans, Louisiana $476M AUM 5.4% 1-Year Est. Return
IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return

NF Trinity Capital's Q3 2017 Portfolio in Review

As of Q3 2017, NF Trinity Capital held 53 positions worth $700M, down 0.71% from $705M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NF Trinity Capital's Q3 2017 filing shows 8 new, 9 increased, 3 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • NF Trinity Capital's largest Q3 2017 buy was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M.
  • NF Trinity Capital added most to Citigroup in Q3 2017, an estimated $8.53M increase.
  • NF Trinity Capital's biggest Q3 2017 reduction was Baidu, cutting an estimated $24.6M.
  • NF Trinity Capital fully exited Acadia Pharmaceuticals in Q3 2017, selling an estimated $5.72M.
  • NF Trinity Capital's ten largest holdings make up 65% of its $700M portfolio in Q3 2017.
  • NF Trinity Capital opened 8 new positions and closed 5 in Q3 2017.
  • NF Trinity Capital's portfolio value fell 0.71% quarter-over-quarter to $700M.

Based on NF Trinity Capital's 13F filing for Q3 2017, filed 7 Nov 2017.